Adaptimmune Therapeutics plc - NASDAQ:ADAP - Comprehensive analysis
Free evaluation through quantitative algorithms Adaptimmune Therapeutics plc - NASDAQ:ADAP
Growth-Scoring Model Detail
Total Revenue Growth Over Prior Year | 147 | Market 100 Sector 94 |
Gross Profit Growth Over Prior Year | 0 | Market 0 Sector 0 |
EBITDA Growth Over Prior Year | 0 | Market 0 Sector 0 |
EBITA Growth Over Prior Year | 0 | Market 0 Sector 0 |
EBIT Growth Over Prior Year | 0 | Market 0 Sector 0 |
Earnings from Cont. Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
Net Income Growth Over Prior Year | 0 | Market 0 Sector 0 |
Normalized Net Income Growth Over Prior Year | 0 | Market 0 Sector 0 |
Diluted EPS before Extra Growth Over Prior Year | 0 | Market 0 Sector 0 |
A/R Growth Over Prior Year | 1485 | Market 100 Sector 100 |
Inventory Growth Over Prior Year | 53 | Market 99 Sector 96 |
PPE Net Growth Over Prior Year | -11.62 | Market 4 Sector 37 |
Total Assets Growth Over Prior Year | 7.01 | Market 64 Sector 67 |
Tangible Book Value Growth Over Prior Year | -13.72 | Market 8 Sector 46 |
Common Equity Growth Over Prior Year | -9.24 | Market 11 Sector 47 |
Cash from Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
CAPEX Growth Over Prior Year | -79.45 | Market 0 Sector 16 |
Dividend per Share Growth Over Prior Year | 0 | Market 35 Sector 49 |
Levered Free Cash Flow Growth Over Prior Year | 0 | Market 0 Sector 0 |
Unlevered Free Cash Flow Growth Over Prior Year | 0 | Market 0 Sector 0 |
Profitability-Scoring Model Detail
Gross Margin % | 18.21 | Market 14 Sector 47 |
SG&A Margin % | 39.8 | Market 92 Sector 49 |
EBITDA Margin % | -15.13 | Market 1 Sector 26 |
EBITA Margin % | -21.4 | Market 1 Sector 26 |
EBIT Margin % | -21.57 | Market 1 Sector 26 |
Earnings from Cont. Ops Margin % | -25.43 | Market 2 Sector 28 |
Net Income Margin % | -25.43 | Market 2 Sector 28 |
Net Income Avail. for Common Margin % | -25.43 | Market 2 Sector 28 |
Normalized Net Income Margin % | -12.9 | Market 1 Sector 30 |
Levered Free Cash Flow Margin % | -8.4 | Market 8 Sector 26 |
Unlevered Free Cash Flow Margin % | -7.82 | Market 6 Sector 26 |
Return on Assets % | -7.68 | Market 1 Sector 68 |
Return on Capital % | -17.59 | Market 0 Sector 60 |
Return on Equity % | -52.96 | Market 1 Sector 48 |
Return on Common Equity % | -52.96 | Market 1 Sector 49 |
Total Asset Turnover | 0.57 | Market 58 Sector 77 |
